MCCN Medcolcanna Organics

CSE Bulletin: New Listing - Medcolcanna Organics Inc. (MCCN)

Toronto, Ontario--(Newsfile Corp. - le 30 novembre/November 2021) - The common shares of Medcolcanna Organics Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at on the trading date.

Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market. Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company’s scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.

_________________________________

Les actions ordinaires de Medcolcanna Organics Inc. ont été approuvées pour inscription au CSE.

Les documents de cotation et d'information seront disponibles sur à la date de négociation.

Medcolcanna est une société canadienne intégrée de cannabis médical, dont les opérations entièrement sous licence sont basées en Colombie. Dirigée par une équipe de direction éprouvée et performante, Medcolcanna possède des installations dans des emplacements de croissance optimaux, ce qui positionne la société pour devenir un leader mondial sur le marché du cannabis médical. Medcolcanna utilise une technologie agricole biologique de pointe et des processus pharmaceutiques innovants pour produire des produits de haute qualité. Le modèle de production évolutif de la société et son réseau de partenariats pharmaceutiques à l'échelle mondiale garantissent qu'ils restent à la pointe de l'industrie du cannabis médical.

Issuer/Émetteur: Medcolcanna Organics Inc.
Security Type/Titre: Common Shares/Actions ordinaires
Symbol(s)/Symbole(s): MCCN
Number of securities issued and outstanding/ Titres émis et en circulation:
Number of Securities reserved for issuance/ Titres réservés pour émission:
CSE Sector/Catégorie: Life Sciences/Sciences biologiques
CUSIP: 58406X 10 5
ISIN: CA 58406X 10 5 0
Boardlot/Quotité:
Trading Currency/Monnaie de négociation: CDN$/$CDN
Trading Date/Date de negociation: Le 1 decembre/December 2021
Other Exchanges/Autres marches: N/A
Fiscal Year end /Clôture de l'exercice financier: le 31 decembre/December
Transfer Agent/Agent des transferts: TSX Trust Company

 

The Exchange is accepting Market Maker applications for MCCN. Please email:

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:

EN
03/12/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medcolcanna Organics

 PRESS RELEASE

CSE Bulletin: New Listing - Medcolcanna Organics Inc. (MCCN)

Toronto, Ontario--(Newsfile Corp. - Le 23 décembre/December 2021) The common shares of Medcolcanna Organics Inc. have been approved for listing on the CSE. Listing and disclosure documents will be available at on the trading date. Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market. Medcolcanna employs state o...

 PRESS RELEASE

CSE Bulletin: New Listing - Medcolcanna Organics Inc. (MCCN)

Toronto, Ontario--(Newsfile Corp. - le 30 novembre/November 2021) - The common shares of Medcolcanna Organics Inc. have been approved for listing on the CSE. Listing and disclosure documents will be available at on the trading date. Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market. Medcolcanna employs state...

 PRESS RELEASE

MCCN Executes Extraction Agreement with Third-Party Cultivator

Bogota, Colombia--(Newsfile Corp. - June 8, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) (FSE: MO2) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of a long-term commercial extraction services agreement with La Finca Interactiva Arachna Inc. SAS ("La Finca"). La Finca is a Colombian based whole-owned subsidiary of Chemesis International Inc (C.CSI). The agreement is for MCCN to provide extraction services for La Finca.This executed commercial execution services a...

 PRESS RELEASE

Medcolcanna Announces Mailing of Materials for AGM on July 7, 2021 and...

Bogota, Colombia--(Newsfile Corp. - June 4, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) (FSE: MO2) ("Medcolcanna", "MCCN" or the "Company"), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, July 7, 2021 at 4:00 p.m. (Bogota time) at the offices of the Company will be held as a virtual meeting at the same time and on the same date. As Colombia has declared a state of public health emergency, and to support efforts to combat the spread of COVID-19, Medcolcanna has made the...

 PRESS RELEASE

MCCN Executes Extraction Agreement with International Cannabis Company

Bogota, Colombia--(Newsfile Corp. - June 1, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of an extraction service agreement with an International Cannabis Company, a company with formulations for health and wellness applications, for depression, anxiety and PTSD, which also has cultivation operations in Colombia.The execution of this commercial extraction agreement is a significant milestone for MCCN. This is the fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch